Prot#GS-US-454-4378: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib, GS-0976, GS-9674, and Combinations in Subjects with Bridging (F3) Fibrosis or Compensated Cirrhosis (F4) due to Nonalcoho

Project: Research project

Project Details

StatusActive
Effective start/end date8/23/188/23/21

Funding

  • PRA Health Sciences (Prot#GS-US-454-4378)
  • Gilead Sciences, Inc. (Prot#GS-US-454-4378)